ReviewFrontiers in medicine2022

Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227.

Peter M Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.